Recombinant human growth hormone has the potential to be a new treatment option for adults who have a deficiency of human growth hormone, a.k.a. HGH. There is now reports that many of the symptoms associated with adult growth hormone deficiency could be reversible with growth hormone replacement therapy. It appears that there are no negative side effects even at low doses of the hormone.

Human growth hormone supplements profoundly alters the make up of the patient's body. Fatty tissue gets condensed and leaner body tissue develops. Developing leaner body tissue is related to things such as enhanced protein, and stronger muscles. After six months of human growth hormone therapy, fat tissue reduces, most notably in the visceral and trunk portions of the body instead of an arm, leg, or neck. This indicates that human growth hormone replacement therapy will turn around the distribution of fat in the opposite direction associated with adult growth hormone deficiency (AGHD) and risks to heart and lung function.

Systemic lipid levels may be positively affected by human growth hormone replacement therapy. According to recent results, short-term treatment of HGH decreased LDL cholesterol, and correlated with increased mRNA expression LDL receptor sites in the liver. Significant reductions in circulating LDL cholesterol have not been consistently observed with GH treatment; therefore, potential benefits of the interaction between GH and LDL receptors require further investigation with longer clinical trials.

Testosterone injections can aid the body's composition. It can also help a system metabolize lipids, improve bone density and cardiovascular function. It can even help psychosomatic well-being. Other issues that must be considered are the official clinical definitions of partial and complete HGH deficiency. You also need to decipher which tests will make the best analysis. Also, many are not sure whether the advantages are a result of pharmacological or physiologic HGH replacement.

Nonetheless, it is obvious that low amounts may be sufficient to achieve the desired metabolic outcome. Ultimate recommendation on dosage and the long term effects of human growth hormone therapy, mostly on cardiovascular morbidity and mortality, will be figured out by the potential studies.

Even though human growth hormone levels reduce with age, it has not been proven that attempting to keep the amounts that are in young people is advantageous. It is believable that age-related hormonal changes may serve as useful markers of physiological aging. However, this has not been shown experimentally for people. Although hormone-replacement exams have yielded some constructive results, it is clear that negative side effects can also take place in the form of risks for cancer, cardiovascular disease, and behavior changes.